1. Executive Summary
2. Research Methodology
3. Transplant Diagnostic
3.1 Overview
3.2 Organ Transplant
3.3 HLA Typing
3.3.1 Overview
3.3.2 Classification
3.3.2.1 Serology
3.3.2.2 Mixed Lymphocyte Culture (MLC)
3.3.2.3 Polymerase Chain Reaction (PCR)
3.3.2.4 Sequencing Based
4. Market Analysis
4.1 Market Sizing (Actual & Forecasted)
4.2 Market Share Analysis
4.2.1 Market Share by Product Type
4.2.2 Market Share by Technology
4.2.3 Market Share by Type of Organ
4.2.4 Market Share by Region
5. Market Segmentation
5.1 HLA Typing
5.1.1 Molecular Assays
5.1.2 Non-Molecular Assays
5.2 Product Type
5.2.1 Reagents & Consumables
5.2.2 Instruments
5.2.3 Software & Services
6. Regional Analysis
6.1 North America
6.1.1 Market Sizing (Actual & Forecasted)
6.1.2 The US
6.2 Europe
6.2.1 Market Sizing (Actual & Forecasted)
6.2.2 Italy
6.3 Asia Pacific
6.3.1 Market Sizing (Actual & Forecasted)
7. Market Dynamics
7.1 Industry Trend & Development
7.1.1 Next Generation Sequencing for HLA Typing
7.1.2 Recent Deals
7.1.3 Other Technological Advancements
7.2 Growth Drivers
7.2.1 Rising Demand for Organ Transplants
7.2.2 Increasing Geriatric Population
7.2.3 Prevalence of Chronic Diseases
7.2.4 Government Initiatives
7.3 Challenges
7.3.1 Organ Shortage for Transplant
7.3.2 Limited Medical Reimbursement
7.3.3 Lack of Awareness
7.3.5 Stringent Regulations
8. Competitive Landscape
9. Company Profiles
9.1 Thermo Fisher Scientific Inc.
9.2 F. Hoffman-La Roche Ltd.
9.3 Abbott Laboratories Inc.
9.4 Qiagen N.V.
9.5 Immucor Inc.